ARYx Therapeutics, Inc. (ARYX)

OTC Markets OTCPK - OTC Markets OTCPK Precio demorado. Divisa en USD

Añadir a la lista de favoritos

0,0000

(0,00%)

A partir del 01:20PM EDT. Mercado abierto.

Accionistas principales

Lista de personas con información privilegiada

Transacciones de accionistas miembros de la empresa

Divisa en USD

Compras de personas con información privilegiada de los 6 últimos meses	Acciones	Trans
Compras	0	0
Ventas	N/A	0
Cuotas netas adquiridas (vendidas)	0	0
Acciones de persona con información privilegiada totales	N/A	N/A
% de acciones netas adquiridas (vendidas)	N/A	N/A

Compras institucionales netas del trimestre anterior al último trimestre	Acciones
Cuotas netas adquiridas (vendidas)	N/A
% de cambio en la posesión de acciones institucionales	N/A

Transacciones comunicadas por la persona con información privilegiada: últimos dos años

Persona con información privilegiada	Transacción	Tipo	Valor	Fecha	Acciones
BASKETT FOREST Beneficial Owner of more than 10% of a Class of Security	Sale at price 0.07 per share.	Indirecto	326.257	10 mar 2011	4.469.270
KERINS PATRICK JOHN Beneficial Owner of more than 10% of a Class of Security	Sale at price 0.07 per share.	Indirecto	326.257	10 mar 2011	4.469.270
KOLLURI KRISHNA KITTU Beneficial Owner of more than 10% of a Class of Security	Sale at price 0.07 per share.	Indirecto	326.257	10 mar 2011	4.469.270
DRANT RYAN D Beneficial Owner of more than 10% of a Class of Security	Sale at price 0.07 per share.	Indirecto	326.257	10 mar 2011	4.469.270
GROWTH EQUITY OPPORTUNITIES FUND L L C Beneficial Owner of more than 10% of a Class of Security	Sale at price 0.07 per share.	Indirecto	326.257	10 mar 2011	4.469.270
NAGLER DAVID Officer	Stock Gift at price 0.00 per share.	Directo	0	21 dic 2009	1.250
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 5.42 per share.	Indirecto	10.848.000	22 may 2009	2.000.000
SIMON NICHOLAS J III Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.20 per share.	Indirecto	3.932.962	14 nov 2008	1.787.710
EVNIN LUKE BASIL Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.20 per share.	Indirecto	3.932.962	14 nov 2008	1.787.710
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.35 per share.	Indirecto	2.854.428	14 nov 2008	1.214.650
MPM BIOVENTURES III QP L P Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.20 per share.	Indirecto	3.932.962	14 nov 2008	1.787.710
ADELMAN ROBERT J Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.35 per share.	Indirecto	2.854.428	14 nov 2008	1.214.650
SIMON NICHOLAS J III Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.89 per share.	Indirecto	2.367.000	13 nov 2007	300.000
SIMON NICHOLAS J III Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Indirecto	0	13 nov 2007	3.281.270
GODDARD PAUL Chief Executive Officer	Conversion of Exercise of derivative security at price 0.00 per share.	Indirecto	0	13 nov 2007	3.021
EVNIN LUKE BASIL Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.89 per share.	Indirecto	2.367.000	13 nov 2007	300.000
EVNIN LUKE BASIL Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Indirecto	0	13 nov 2007	3.276.868
ORBIMED ADVISORS, L.L.C. Unknown	Purchase at price 7.89 per share.	Indirecto	2.367.000	13 nov 2007	300.000
ORBIMED ADVISORS, L.L.C. Unknown	Conversion of Exercise of derivative security at price 0.00 per share.	Indirecto	0	13 nov 2007	1.825.490
MPM BIOVENTURES III QP L P Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.89 per share.	Indirecto	2.367.000	13 nov 2007	300.000
MPM BIOVENTURES III QP L P Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Indirecto	0	13 nov 2007	3.276.868
ADELMAN ROBERT J Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.89 per share.	Indirecto	2.367.000	13 nov 2007	300.000
ADELMAN ROBERT J Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Indirecto	0	13 nov 2007	1.825.493
DRUZGALA PASCAL Officer	Conversion of Exercise of derivative security at price 0.00 per share.	Directo	0	13 nov 2007	1.122
MILNER PETER G Officer and Director	Conversion of Exercise of derivative security at price 0.00 per share.	Indirecto	0	13 nov 2007	47.739
NOMURA PHASE4 VENTURES LTD Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.00 per share.	Indirecto	0	13 nov 2007	2.447.730

IBEX 3511.404,90-39,10(-0,34%)

Euro Stoxx 505.051,31-17,78(-0,35%)

Dólar/Euro1,0813-0,0081(-0,75%)

Petróleo Brent79,63-0,24(-0,30%)

Oro2.327,10-63,80(-2,67%)

Bitcoin EUR65.816,40+54,23(+0,08%)

ARYx Therapeutics, Inc. (ARYX)

Transacciones de accionistas miembros de la empresa

Transacciones comunicadas por la persona con información privilegiada: últimos dos años

IBEX 35
11.404,90
-39,10(-0,34%)

Euro Stoxx 50
5.051,31
-17,78(-0,35%)

Dólar/Euro
1,0813
-0,0081(-0,75%)

Petróleo Brent
79,63
-0,24(-0,30%)

Oro
2.327,10
-63,80(-2,67%)

Bitcoin EUR
65.816,40
+54,23(+0,08%)